Ledger.Open graph →
SEC Form D · filed June 11, 2018

Ashvattha Therapeutics, LLC

Offering
$400K
Sold
$400K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
REDWOOD CITY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jeffrey Cleland · San Carlos, CAExecSujatha Kannan · Highland, MDExecKannan Rangaramanujam · Highland, MDExecMelissa A. Mcgrane · Miami, FLExecAndrew D. Bonanno · MOUNT KISCO, NYExecSanju N. Bansal · MCLEAN, VAExecAhmed D. Wahla · MOUNT KISCO, NYExecMark N. Larow · MCLEAN, VAExecClaiborne Williams · Los Angeles, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗